DOI: 10.14704/nq.2017.15.3.1113

An Investigation of the Psychometric Properties of Illness Perception Questionnaire for Schizophrenia (IPQS) in Iran

Somayeh Shokrgozar, Robabeh Soleimani Soleimani, Elahe Abdollahi, Mahnaz Fallahi, Mahboube Roshandel, Seyyedeh Zahra Seyyed Noori


The present study has been carried out in order to evaluate psychometric characteristics of Illness Perception Questionnaire for Schizophrenia. This is a descriptive correlational research. The study population consisted of all patients with schizophrenia aging 19 to 70 years old who were hospitalized in the Psychiatric Ward of Shafa Hospital, Rasht (2016). Out of this population, a sample size of 95 people was obtained using purposive sampling, Demographic Questionnaire, Illness Perception Questionnaire for Schizophrenia (IPQS), Positive and Negative symptoms Scale (PNSS), Scale to Assess Unawareness in Mental Disorder (SUMD), Beck Depression Inventory (BDI), and Calgary Depression Scale for Schizophrenia (CDSS). Exploratory factor analysis revealed that this questionnaire is composed of 10 dimensions, the first of which explaining 24.402 percent of all of variance. Besides, concurrent validity showed that the total IPQS score had a significant correlation with SUMD equal to 0.579 at the level of 1 percent; this correlation was 0.29 at the level of 5 percent and 0.615 at the level of 1 percent in relation to BDI and CDSS, respectively. However, no correlation was observed between IPQS score and PANSS. Cronbach's alpha coefficients of reliability for IPQS scale were 0.705, and, for the subscales, between 0.599 and 0.865. This result suggests a good reliability for the Illness Perception Questionnaire for Schizophrenia. The Illness Perception Questionnaire for Schizophrenia has helpful psychometric properties that make it an appropriate analysis tool.


Psychometric Properties, Illness Perception Questionnaire, Schizophrenia

Full Text:



Addington D, Addington, J Maticka-Tyndale E, Joyce, J. Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia research 1992; 6(3): 201-208.

American Psychiatric Association, Diagnostic and statistical manual of mental disorders, (DSM-5®): American Psychiatric Pub 2013.

Cavelti M, Contin G, Beck E.M, Kvrgic S, Kossowsky J, Stieglitz R.D, Vauth R. Validation of the Illness Perception Questionnaire for Schizophrenia in a German-speaking sample of outpatients with chronic schizophrenia. Psychopathology 2012; 45(4): 259-269.

Clifford C. Compliance with medication in psychiatric patients: The self-regulatory model and the health belief models. Master of Health Psychology Thesis, University of Surrey 1998.

Cooper A, Lloyd G, Weinman J, Jackson G. Why patients do not attend cardiac rehabilitation: role of intentions and illness beliefs. Heart 1999; 82(2): 234-236.

Esfand Abadi SH. Psychology of Individual differences. Samt. Tehran 2006; 109-110.

Hair J, Black W.C, Babin B.J, Anderson R.E, Tatham R.L, SEM: An introduction. Multivariate data analysis: A global perspective 2010. 629-686.

Hani Y, Ghuloum S, Mahfoud, Z, Opler M, Khan A, Yehya A, Abdulhakam A, Hammoudeh S, Al-Mujalli A, Elsherbiny, R, Al-Amin H. Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia 2016;11(9): 16-23.

Harvey P.D and Rosenthal J.B, Treatment resistant schizophrenia: course of brain structure and function. Progress in Neuro-Psychopharmacology and Biological Psychiatry2016: 70(6):111-116.

Karimi Y. social Psychology. Arasbaran Tehran, 2006.

Leventhal H, Nerenz DR, Purse J. Illness representations and coping with health threats. Handbook of Psychology and Health, 1984.

Lobban F, Barrowclough C, Jones S. A review of the role of illness models in severe mental illness. Clinical psychology review2003; 23(2):171-196.

Lobban F, Barrowclough C, Jones S. The impact of beliefs about mental health problems and coping on outcome in schizophrenia. Psychological Medicine2004: 34(7); 1165-1176.

Lobban F, Barrowclough C, Jones S. Assessing cognitive representations of mental health problems. I. The illness perception questionnaire for schizophrenia. British Journal of Clinical Psychology. 2005; 44(2):147-162.

Morrison A.P. The interpretation of intrusions in psychosis: an integrative cognitive approach to hallucinations and delusions. Behavioral and Cognitive Psychotherapy, 2001; 29(3): 257-276.

M0khtarzadeh A, Ghoreyshizadeh S, Pezeshki M.Z, Ranjbar K.f. Reliability and validity of abridged version of the farsi version of scale to Assess Unawareness of Mental Disorders (SUMD) in psychotic mania2010;16(3):181-186.

Myles J.B, Rossell S.L, Phillipou A, Thomas E, Gurvich C. Insights to the schizophrenia continuum: A systematic review of saccadic eye movements in schizotypy and biological relatives of schizophrenia patients. Neuroscience & Biobehavioral Reviews.2017; 72(4) 278-300.

Nose M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological medicine. 2003; 33(7): 1149-1160.

Papp L.M, Goeke-Morey M.C, Cummings E.M. Linkages between spouses' psychological distress and marital conflict in the home. Journal of Family Psychology. 2007; 21(3): 533.

Perälä J, Suvisaari J, Saarni S.I, Kuoppasalmi K, Isometsä E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppä T, Härkänen T. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of general psychiatry.2007; 64(1):19-28.

Petrie K.J, Jago L.A, Devcich D.A. The role of illness perceptions in patients with medical conditions. Current opinion in psychiatry. 2007;20(2):163-167.

Roelofs J, van Breukelen G, de Graaf L.E, Beck A.T, Arntz A. Huibers M.J.. Norms for the Beck Depression Inventory (BDI-II) in a large Dutch community sample. Journal of Psychopathology and Behavioral Assessment.2013; 35(1): 93-98.

Saki K and Bagheri M. Study of effective factors in the incidence of schizophrenia in Ilam City. Ilam University of Medical Science. 2004; 11(40):13-19.

Shah P, Hull, T and Riley G.A. Associations between the Illness Perception Questionnaire for Schizophrenia and engagement in treatment in a secure setting. Clinical Psychologist.2009; 13(2):69-74.

Stafford L, Jackson H.J, Berk M. Illness beliefs about heart disease and adherence to secondary prevention regimens. Psychosomatic Medicine. 2008; 70(8) 942-948.

Talley S.L. Self-regulation activities used by individuals with schizophrenia. University of Utah, 1998.

Verma D, Srivastava M.K, Singh S.K, Bhatia T, Deshpande, S.N. Lifetime suicide intent, executive function and insight in schizophrenia and schizoaffective disorders. Schizophrenia research. 2016;178(1):12-16.

Supporting Agencies

| NeuroScience + QuantumPhysics> NeuroQuantology :: Copyright 2001-2019